Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease

Vinod Burade,1 Rishit Zalawadia,1 Alpesh Patel,1 Abayomi Ogundele2 1Sun Pharmaceutical Industries Limited, Vadodara, Gujarat, India; 2Sun Pharmaceutical Industries, Inc, Princeton, NJ, USACorrespondence: Abayomi OgundeleSun Pharmaceutical Industries, Inc, Princeton, NJ, USATel +1 (609) 720-5389Email...

Full description

Bibliographic Details
Main Authors: Burade V, Zalawadia R, Patel A, Ogundele A
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Clinical Ophthalmology
Subjects:
cyclosporine a
goblet cell density
keratoconjunctivitis sicca
preclinical
tear production
Online Access:https://www.dovepress.com/preclinical-efficacy-comparison-of-cyclosporine-ophthalmic-solution-00-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/preclinical-efficacy-comparison-of-cyclosporine-ophthalmic-solution-00-peer-reviewed-article-OPTH

Similar Items